# Attenuating effects of inflammatory pathway by prolonged left ventricular unloading after myocardial infarction in male rats

**Authors:** Jingwen Gao, Yasushige Shingu, Ryota Azuma, Satoru Wakasa, Vincenzo Lionetti, Vincenzo Lionetti, Vincenzo Lionetti, Vincenzo Lionetti, Vincenzo Lionetti

PMC · DOI: 10.1371/journal.pone.0343702 · PLOS One · 2026-02-26

## TL;DR

This study shows that left ventricular unloading after heart attacks in rats reduces inflammation and protects heart function.

## Contribution

The study reveals that unloading reduces inflammation and preserves M2 macrophage levels in post-infarction hearts.

## Key findings

- Partial left ventricular unloading mitigates cardiac function decline after myocardial infarction.
- Unloading attenuates the upregulation of pro-inflammatory cytokines TNFα and IL1β.
- Unloading preserves M2 macrophage levels and modulates macrophage polarization.

## Abstract

Inflammatory response plays a pivotal role in myocardial injury and post-infarction remodeling after acute myocardial infarction (AMI). Mechanical unloading (UL) of the left ventricle (LV) has been proposed as a potential therapeutic strategy to preserve cardiac function; however, its effects on myocardial inflammation remain incompletely understood.

We employed a rat model of partial UL using heterotopic heart-lung transplantation following AMI. RNA sequencing (RNA-seq) was performed to evaluate transcriptomic changes, with a specific focus on inflammatory pathways in the non-infarcted remote area. Immune cell abundance was estimated using deconvolution analysis (QUANTISEQ). Quantitative PCR was performed to analyze some inflammatory cytokines, and macrophage polarization was evaluated by immunohistochemistry.

AMI significantly impaired cardiac function, which was mitigated by UL. RNA-seq analysis revealed marked activation of inflammatory pathways and identified several hub genes involved in cytokine signaling following AMI, while these transcriptional changes were not significantly altered in UL groups after AMI. Immune cell profiling demonstrated an increase in M2 macrophages after AMI, while UL preserved M2 macrophage levels. Histological analysis further supported UL’s modulatory effect on macrophage polarization. Pro-inflammatory cytokines TNFα and IL1β were upregulated after AMI but showed attenuation with UL.

Partial UL potentially attenuates cardiac functional deterioration after AMI while exerting substantial effects on inflammatory gene expression and macrophage polarization. These findings suggest that the cardioprotective effects of UL may be correlated with the modulation of inflammatory pathways in the remote area after AMI.

## Linked entities

- **Proteins:** TNF (tumor necrosis factor), IL1B (interleukin 1 beta)
- **Diseases:** myocardial infarction (MONDO:0005068)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** Prkaa1 (protein kinase AMP-activated catalytic subunit alpha 1) [NCBI Gene 65248] {aka AMPKalpha1}, Ctnnb1 (catenin beta 1) [NCBI Gene 84353] {aka Catnb}, IL2RA (interleukin 2 receptor subunit alpha) [NCBI Gene 3559] {aka CD25, IDDM10, IL2R, IMD41, TCGFR, p55}, TCF7L2 (transcription factor 7 like 2) [NCBI Gene 6934] {aka TCF-4, TCF4}, Tcf7l2 (transcription factor 7 like 2) [NCBI Gene 679869], Cd163 (CD163 molecule) [NCBI Gene 312701] {aka ED2}, Axin2 (axin 2) [NCBI Gene 29134] {aka axil, axin-2}, tumor necrosis factor [NCBI Gene 103694380], Nos2 (nitric oxide synthase 2) [NCBI Gene 24599] {aka Nos2a, iNos}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, Lcp2 (lymphocyte cytosolic protein 2) [NCBI Gene 155918] {aka Slp76}, Lrp6 (LDL receptor related protein 6) [NCBI Gene 312781], IL1R2 (interleukin 1 receptor type 2) [NCBI Gene 7850] {aka CD121b, CDw121b, IL-1R-2, IL-1RT-2, IL-1RT2, IL1R2c}, Il1b (interleukin 1 beta) [NCBI Gene 24494] {aka IL-1F2}, Tnf (tumor necrosis factor) [NCBI Gene 24835] {aka RATTNF, TNF-alpha, Tnfa}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Prkcb (protein kinase C, beta) [NCBI Gene 25023] {aka Pkcb, Prkcb1}, Cx3cr1 (C-X3-C motif chemokine receptor 1) [NCBI Gene 171056] {aka Rbs11}, Hagh (hydroxyacyl glutathione hydrolase) [NCBI Gene 24439] {aka Glo2, RSP29}, Cd4 (Cd4 molecule) [NCBI Gene 24932] {aka W3/25, p55}, Prkaa2 (protein kinase AMP-activated catalytic subunit alpha 2) [NCBI Gene 78975] {aka Ampk, Ampka2}, RT1-Db1 (RT1 class II, locus Db1) [NCBI Gene 294270] {aka Db1, RT1-Db, RT1-Db1n}, Il1r2 (interleukin 1 receptor type 2) [NCBI Gene 117022], LRP6 (LDL receptor related protein 6) [NCBI Gene 4040] {aka ADCAD2, EVR8, OPTA4, STHAG7}, AXIN2 (axin 2) [NCBI Gene 8313] {aka AXIL, ODCRCS}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, Pcsk1 (proprotein convertase subtilisin/kexin type 1) [NCBI Gene 25204] {aka BDP, PC1, PC3}, Spp1 (secreted phosphoprotein 1) [NCBI Gene 25353] {aka OSP}, Il2ra (interleukin 2 receptor subunit alpha) [NCBI Gene 25704] {aka IL2RAC}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}
- **Diseases:** ischemia (MESH:D007511), intraventricular (MESH:D006345), distress (MESH:D012128), myocardial (MESH:D009202), LVEDD (MESH:D018487), hemorrhagic (MESH:D006470), STEMI (MESH:D000072657), Cardiac arrest (MESH:D006323), ventricular function impairment (MESH:D018754), atrophy (MESH:D001284), cardiogenic shock (MESH:D012770), tumor (MESH:D009369), myocardium (MESH:D017682), pain (MESH:D010146), myocardial remodeling (MESH:D064752), Inflammation (MESH:D007249), host disease (MESH:D004194), Fibrosis (MESH:D005355), tissue injury (MESH:D017695), overdose (MESH:D062787), necrosis (MESH:D009336), LV remodeling (MESH:D020257), cardiac (MESH:D006331), inflammatory cytokines (MESH:D000080424), heart failure (MESH:D006333), infarct (MESH:D007238), dilation (MESH:D002311), AMI (MESH:D009203), immunologic (MESH:D007154), Myocardial ischemia (MESH:D017202), death (MESH:D003643), thrombus (MESH:D013927)
- **Chemicals:** drinking water (MESH:D060766), Krebs-Henseleit buffer (MESH:C074097), water (MESH:D014867), aspirin (MESH:D001241), pentobarbital (MESH:D010424), FITC (MESH:D016650), xylazine (MESH:D014991), secobarbital sodium (MESH:D012631), O2 (MESH:D010100), paraffin (MESH:D010232), 4',6-diamidino-2-phenylindole (MESH:C007293), formalin (MESH:D005557), eosin (MESH:D004801), heparin (MESH:D006493), Ketalar (MESH:D007649), CO2 (MESH:D002245), fatty acid (MESH:D005227), hematoxylin (MESH:D006416), Alexa Fluor  Plus 594 (-), bile acid (MESH:D001647)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116]
- **Cell lines:** S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232), 293 — Homo sapiens (Human), Transformed cell line (CVCL_0045), -MTAB-16419 — Homo sapiens (Human), Transformed cell line (CVCL_LN84)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12944788/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12944788/full.md

## References

26 references — full list in the complete paper: https://tomesphere.com/paper/PMC12944788/full.md

---
Source: https://tomesphere.com/paper/PMC12944788